Proteasome inhibitors MG-132 and bortezomib induce AKR1C1, AKR1C3, AKR1B1, and AKR1B10 in human colon cancer cell lines SW-480 and HT-29. (Q42760214)
Jump to navigation
Jump to search
scientific article published on 6 January 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Proteasome inhibitors MG-132 and bortezomib induce AKR1C1, AKR1C3, AKR1B1, and AKR1B10 in human colon cancer cell lines SW-480 and HT-29. |
scientific article published on 6 January 2011 |
Statements
1 reference
Proteasome inhibitors MG-132 and bortezomib induce AKR1C1, AKR1C3, AKR1B1, and AKR1B10 in human colon cancer cell lines SW-480 and HT-29. (English)
1 reference
1 reference
Bettina Ebert
1 reference
Michael Kisiela
1 reference
Edmund Maser
1 reference
6 January 2011
1 reference
1 reference
Identifiers
1 reference